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Tumour oxygenation has been shown to play an important role in
radiotherapeutic response both in experimental tumours and in the
clinic. To eliminate microregions of hypoxia, i.e. low oxygenation,
numerous strategies have been used, generally aiming either to
increase oxygen delivery to the tumour (Horsman et al, 1994) or to
directly target the hypoxic cells using radiosensitizers or hypoxic
cell cytotoxic agents (Brown and Giaccia, 1994). Several recent
reports have also suggested the use of angiogenesis inhibitors
(Klauber et al, 1997; O￿Reilly et al, 1997) or thrombocytic agents
(Huang et al, 1997) to directly target the tumour vasculature. A
major shortcoming in evaluating the use of any of these
approaches, however, is the inability to adequately quantify and
understand the accompanying changes in tumour physiology.
The current study presents a method for combining several
sophisticated techniques to obtain a comprehensive two-dimen-
sional mapping of the relationships among tumour vascular
configuration, oxygen transport and hypoxic development. First,
tumour oxygen availability is spatially defined by measuring
intravascular blood oxygen saturations (HbO2) cryospectrophoto-
metrically in a frozen tumour block. Second, hypoxic develop-
ment, in relation to the intravascular oxygen availability, is
quantified in an adjacent histological section, using immunohisto-
chemical detection of a recently developed nitroheterocyclic
hypoxia marker (EF5). Third, a combination of fluorescent and
immunohistological stains is used to define the distribution of
distances from the viable tumour cells to the nearest anatomical or
perfused blood vessel.
MATERIALS AND METHODS
Mice and tumour models
The KHT tumour, a sarcoma maintained in vivo, was passaged
approximately every 2 weeks by i.m. inoculation of single-cell
suspensions prepared by a mechanical dissociation procedure
(Thomson and Rauth, 1974). Using 6- to 8-week-old female
C3H/HeJ mice (Jackson Laboratories, Bar Harbor, ME, USA),
2´105KHT cells were inoculated i.m. into the hind limbs. Tumours
were selected for analysis when they reached volumes of between
320 and 1100 mm3 (as measured by callipers (volume = pldiam-
eter3/6). Guidelines for the humane treatment of animals were
followed as approved by the University Committee on Animal
Resources.
Injection of fluorescent stains and EF5 hypoxic marker
Localized areas of tumour hypoxia were assessed in frozen tissue
sections by immunohistochemical identification of sites of 2-nitro-
imidazole metabolism. A pentafluorinated derivative (EF5) of
etanidazole (synthesized by Dr R Vishnuvajjala of the National
Cancer Institute) was injected i.v., 1 h before tumour freezing (0.2 ml
of 10 mMEF5). Protein conjugates of EF5 have been used previously
to immunize mice from which monoclonal antibodies were devel-
oped (Lord et al, 1993). These antibodies are extremely specific for
the EF5 drug adducts that form when the drug is incorporated by
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hypoxic cells, and one of these, ELK3-51, has been well character-
ized. Regions of high EF5 metabolism in multicellular tumour
spheroids, as well as murine and rat tumours, were visualized
immunochemically using a fluorochrome (Cy3, Amersham) conju-
gated to the ELK3-51 antibody. To visualize blood vessels open to
flow, either of two intravascular injected stains was used. The bis-
benzamide Hoechst 33342 (H33342, Molecular Probes, Eugene, OR,
USA) was injected into the tail vein 1 min before tumour freezing, at
a concentration of 7.5 mg kg—1 in saline (0.05 ml). This DNA-binding
stain emits blue fluorescence and preferentially stains tumour cells
adjacent to blood vessels (Olive and Durand, 1987; Trotter et al,
1989a). H33342 is removed very rapidly from the circulation (half-
life of 2 minutes) and has been shown to be very stable once bound to
DNA (Smith et al, 1988). As an alternative, DiOC7(3) (Molecular
Probes) was also tested in a second group of tumours. Injections were
administered i.v. 1 min before tumour freezing at a concentration of
1.0 mg kg—1 (dissolved in 75% dimethyl sulphoxide in phosphate-
buffered saline). This dose has been shown to provide optimal
visualization of tumour vasculature by preferentially staining
cells immediately adjacent to blood vessels (Trotter et al, 1989b).
DiOC7(3) is removed very rapidly from the circulation (half-life of
3 min) and emits green fluorescence when excited by blue light (450
to 490-nm excitation, 510-nm dichroic, and 520-nm barrier filter). To
eliminate potential artifacts related to the possible influence of the
fluorescent stains on HbO2 measurements, as well as the added stress
due to the i.v. injections, separate tumour groups were used to: (1)
relate EF5 uptake to corresponding intravascular HbO2 determina-
tions and (2) relate EF5 uptake to the various vascular markers.
Tumour freezing and sectioning
To accelerate the freezing procedures and ensure that HbO2 satura-
tions were unchanged during freezing, tumours were first shaved,
and a depilatory agent was applied. At appropriate times after treat-
ment, the mice were cervically dislocated, and the tumours were
immediately quick-frozen using a liquid nitrogen-cooled copper
block and stored in cryotanks for later cryospectrophotometric
analysis. Tumours for the HbO2 analysis were sectioned using a
strictly observed protocol: (1) tumours were first cut to approxi-
mately 5-mm cubes under liquid nitrogen, using a chisel; (2) tumours
were then transferred to a —20°C cryostat and allowed to equilibrate
under a liquid nitrogen-cooled stream of nitrogen gas for 10 min; (3)
70—80 14-mm thin sections were quickly cut and discarded, to reach a
location nearer the tumour centre; (4) a jig holding four pins was used
to pierce four defined reference holes into the tumour block (encom-
passing a roughly 4´5 mm area on one face of the tumour cube); (5)
section thickness was set to 4.0-mm and another ten sections were
quickly sliced (and discarded) under the cooled nitrogen gas, to
prevent oxygen uptake in the tumour blood vessels during the
sectioning; (6) the final two 4.0-mm sections (one for the immunohis-
tochemistry control) were cut and mounted on poly-L-lysine-coated
glass slides for later staining and imaging; and (7) the tumour block
and cryostat mounting chuck was quickly removed and returned to
the liquid nitrogen. Glass slides were stored at —20°C until imaged
and stained. Tumour blocks could be stored indefinitely in liquid
nitrogen before performing the cryospectrophotometric analysis.
Cryospectrophotometric determination of intravascular
HbO2 saturations
For HbO2 determinations, the exposed tumour surfaces were
analysed on a liquid nitrogen-cooled microscope stage.
Approximately 150 blood vessels were quantified per tumour,
using green light to enhance visual contrast of the red blood cells,
and selecting all vessels of diameter ‡ 8 mm (determined using an
eyepiece reticle) that were located within the imaged region (see
below). Spatial positions of the blood vessels (and reference
pinholes) were recorded using stage micrometers, and intravas-
cular HbO2 saturations were determined cryospectrophotometri-
cally, as previously described in detail (Fenton and Gayeski,
1990). Briefly, HbO2 saturations were calibrated as a function of
reflected light intensity at three discrete wavelengths, based on the
spectral differences between oxy- and deoxy-haemoglobin. This
means that only vessels containing red blood cells could be quan-
tified, and all haemoglobin in a given vessel was averaged to
obtain the final per cent oxyhaemoglobin. As optical density also
varies as a function of haemoglobin concentration and light path-
length, the intensities at the three wavelengths were combined to
normalize the measurement and to cancel out these dependencies,
thus allowing vessels of widely varying haematocrit to be analysed
using a single calibration curve. HbO2 saturations were stored on
disk with corresponding X and Y spatial coordinates.
Immunohistochemistry
Immediately after cryostat sectioning, tumour slices were imaged
for either H33342 or DiOC7(3) staining (as detailed below).
Sections were then stored at —20°C (for up to 3 days, if necessary),
before beginning the PECAM-1 [platelet endothelial cell adhesion
molecule (Vecchi et al, 1994), also referred to as CD31] and EF5
hypoxic marker staining. On day 1 of this staining procedure,
sections were fixed in cold 4% paraformaldehyde for 1 h, washed
in phosphate-buffered saline (PBS), blocked in 5% normal mouse
serum, washed in PBS and incubated with a 1:100 dilution of rat
anti-mouse CD31 monoclonal antibody IgG2a,k (MEC 13.3,
PharMingen, San Diego, CA, USA) overnight at 4°C in a humid
box. Slides were brought to room temperature at the start of day
two, rinsed in a series of PBS washes, quenched in 3% hydrogen
peroxide and incubated with a 1:25 dilution of peroxidase-conju-
gated mouse anti-rat IgG, (H+L) (Jackson Immunoresearch
Laboratories, West Grove, PA, USA) for 1 h at room temperature
in a humid box. After a PBS wash, sections were incubated with
the chromagen AEC (3-amino-9-ethylcarbazole, AEC Substrate
Kit for Horseradish Peroxidase, Vector Laboratories, Burlingame,
CA, USA) for 30 min, at room temperature and in the dark. All
remaining staining and imaging steps were also performed in the
dark to minimize the loss of light-sensitive AEC staining intensity.
After AEC incubation, sections were washed in a series of distilled
water and PBS, blocked with 5% normal mouse serum and
incubated with 100 ml of ELK3-51/Cy3 anti-EF5 antibody at
75 mg ml—1 overnight at 4°C in a humid box. On day 3, sections
were washed three times in PBS and fixed again in 1%
paraformaldehyde for at least 10 min. Sections were then cover-
slipped with PBS and imaged. Each tumour section had a corre-
sponding control, incubated with buffer in place of antibodies and
stained with AEC, to account for non-specific staining.
Imaging equipment and procedures
The stained sections were imaged using an epi-fluorescence
equipped Nikon microscope with 100 W mercury lamp illumina-
tion (10´/NA 0.3 and 20´/NA 0.5 objectives), digitized
(FlashPoint frame grabber and Hitachi 3-CCD HV-C20 colour466 BM Fenton et al
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video camera), background-corrected and image-analysed using
Image Pro software (Version 3.0, Media Cybernetics, Silver
Spring, MD, USA) and a 133-MHz Pentium computer (96 Mb
RAM). Colour images from adjacent microscope fields were auto-
matically acquired and digitally combined (using a customized
Image-Pro macro) to form 4´4 montages of the tumour cross-
section (using the Image Pro Stage-Pro module, in conjunction
with a Maertzhauser motorized stage and a Prior controller for the
stage stepping motors). Single image frames were 640´480 pixels
(corresponding to 579´434 mm on the histological slide, for the
20´ objective), and 4´4 montages were 2520´1880 pixels (corre-
sponding to 2.28´1.70 mm). For the 10´EF5 images, 6´6
montages corresponded to 6.94´5.18 mm.
Each section was scanned under each of four different staining
conditions. First, epi-illumination images of the fluorescent blue
H33342 staining (4´4 montages at 20´) were obtained immedi-
ately after the 4.0-mm sections were sliced on the cryostat (Figure
1). UV excitation was at 330—380 nm, with a 400-nm dichroic and
a 420-nm barrier filter (UV-2A filter cube), and care was taken to
avoid both normal tissue and sectioning artifacts. On day 3, after
the immunohistochemical staining procedures were completed, the
same tumour section used for the H33342 imaging was returned to
the microscope stage and automatically rescanned using the same
coordinates as for the initial 4´4 montages. Under epi-illumination
(TRITC filter cube: 530- to 550-nm excitation, 565-nm dichroic
and 580-nm barrier filter), fluorescent red-orange 4´4 (20´)
montages were obtained showing the distribution of the Cy3
hypoxia staining (Figure 2). Next, using transmitted light (100 W
Hg), matching brownish-red montages of the PECAM-1/CD31
staining were acquired (Figure 3). All fluorescent images of the
EF5 hypoxic marker were obtained before the use of transmitted
light for imaging of PECAM-1/CD31 staining, to prevent fading
of the EF5 staining. Although AEC is light sensitive, the use of
transmitted light does not decrease AEC staining intensity during
the time required to obtain images of PECAM-1/CD31 staining.
Finally, matched haematoxylin and eosin-stained images were
taken to visualize cellular structures and necrosis (Figure 4).
RESULTS
Image processing
PECAM-1 image enhancement
The PECAM-1 image (anatomical blood vessels) was enhanced by
first using the Image Pro ￿colour segmentation￿ to identify blood
vessels marked with the AEC stain. Specific 3´3 pixel colour
samples were interactively selected and accumulated to obtain
optimal discrimination between vessels and stroma (as determined
visually), and a binary image of the selected colours was created.
For automated counting of the vascular structures, the binary
image was first subjected to a filtering operation (an 11´11 binary
closing to fill in the gaps between contiguous endothelial cells of
the same blood vessel) as shown in Figure 5. Here, the enhanced
blood vessels are superimposed over the EF5/Cy3 staining to
Figure 1 An enlarged portion of the Hoechst 33342-stained montage.
Vessels open to flow at the time of tumour freezing are identified by brightly
blue stained cells around the vessel lumens. Bar = 100 mm
Figure 2 EF5/Cy3-stained section corresponding to the area shown in
Figure 1. The most hypoxic regions are identified by the most brightly stained
red regions at the right, and correspond to the regions of Figure 1 in which no
open blood vessels are located. Bar = 100 mm
Figure 3 PECAM-1/CD31-stained section corresponding to the areas
shown in Figures 1 and 2. This stain preferentially marks endothelial cells
and therefore highlights all blood vessels, whether open or closed to flow.
Although blood vessels are present in the hypoxic regions highlighted in
Figure 2, these vessels are generally not open to flow. Bar = 100 mm
Figure 4 Haematoxylin and eosin-stained section corresponding to Figures
1–3. This slide illustrates that the increased EF5 staining in Figure 2 does not
correspond to regions of necrosis. Bar = 100 mmMeasures of tumour vascular development and hypoxia 467
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allow visualization of the relationships between hypoxia and
vascular configuration. For the counting operation, vascular struc-
tures of area less than 10 mm2 (corresponding to vessels less than
3.5 mm in diameter) were removed, and an area of interest (AOI)
was outlined to omit artifacts and normal tissue. For each image
montage, the overall area scanned and overall vascular density, as
well as the X and Y spatial coordinates for each individual blood
vessel, were stored on disk for later analysis.
H33342 image enhancement
The H33342 stained vessels (perfused blood vessels) were simi-
larly colour segmented, binarized and filtered. However, as the
H33342 diffuses outward from the blood vessels, closely neigh-
bouring vessels could not always be distinguished and counted
automatically (Figure 6). For this reason, the enhanced PECAM-1
and H33342 images were combined using the logical ￿AND￿ oper-
ation (in which only pixels that are ￿on￿ in both images will be ￿on￿
in the resulting image) to form a new image in which only those
PECAM-1 vessels containing H33342 were counted. This image
was again subjected to a binary closing operation to fill in the gaps
between closely aligned vascular elements (Figure 7).
DiOC7(3) image enhancement
As an alternative to the H33342, the carbocyanine dye, DiOC7(3)
(Molecular Probes; 450- to 490-nm excitation, 510-nm dichroic
and 520-nm barrier) was also tested in a second group of tumours,
as shown in Figure 8A. The DiOC7(3) image was colour segmented
using a predefined range of colours, and filtered twice (a 2´2
erosion and a 3´3 dilation), resulting in the enhanced image shown
in Figure 8B. The DiOC7(3) enhanced images have several advan-
tages over the H33342 enhancements shown in Figure 6: (1) the
colour of the DiOC7(3) fluorescence varies over a very limited
range, allowing a fixed colour range to be used and eliminating the
manual colour segmentation; (2) the DiOC7(3) stain does not
A
B
Figure 6 Enhanced image of the Hoechst 33342 staining shown in Figure
1, showing that perfused blood vessels (shown as white areas) are generally
absent in the brightest stained regions of hypoxia (superimposed over the
EF5/Cy3 image). See text for details
Figure 8 (A) An enlarged portion of the DiOC7(3) stained montage. Vessels
open to flow at the time of tumour freezing are identified by brightly green-
stained cells around the vessel lumens. (B) Enhanced image of this same
field
Figure 7 Image resulting from a logical ‘AND’ operation on Figure 5 and 6
(superimposed over the EF5/cy3 image). As Hoechst 33342 staining does
not precisely delineate vascular dimensions, this enhanced image illustrates
which of the PECAM-1/CD31-stained vessels are open to flow (perfused
vessel density = 95 vessels mm–2). Regions lacking both EF5/Cy3 staining
and perfused blood vessels may also correspond to intermittently closed
vessels (see text for details)
Figure 5 Enhanced image of the PECAM-1/CD31 staining shown in Figure
3 (superimposed over the EF5/Cy3 image), showing that blood vessels
(shown as white areas) are located in the brightest stained hypoxic regions
(total vessel density = 189 vessels mm–2). See text for details468 BM Fenton et al
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diffuse as far from the vessels as the H33342, resulting in a much
more precise count of individual vessels (Figure 9); and (3)
perfused vascular density can be obtained directly, without
requiring the logical addition of the DiOC7(3) and PECAM images.
Registration of EF5 and HbO2 images
Because of potential vasoactivity of the H33342 and DiOC7(3)
staining, as well as the stress due to the i.v. injections, separate
tumours were used to relate EF5 staining to corresponding intravas-
cular HbO2 determinations. For these studies, a 10 ´ image (6´6
montage) of the EF5 hypoxic marker distribution was selected to
encompass the four pin-hole reference points in the section. This
10´ montage was spatially aligned with the corresponding intravas-
cular HbO2 saturation map as follows. First, the HbO2 data were
converted to a two-dimensional bubble plot (Sigmaplot, Version
3.03, Jandel Scientific), in which the red intensities of the indi-
vidual points were proportional to the individual HbO2 measure-
ments. The coordinates of the four pin-hole reference points were
also included on this plot as green bubbles. This image was
captured (HiJaak Graphics Suite 95) and opened in Image Pro.
Using the reference pin-hole locations in both the EF5 and the
HbO2 images, and the Image Pro registration tool, the HbO2 image
was translated, rotated and scaled to match the EF5 image. Next, an
AOI was defined to encompass all of the HbO2 measurements, and
the following information was saved on disk: (1) the X and Y coor-
dinates of each vessel; (2) the red intensity of each vessel (which
was later converted back to HbO2 saturations); and (3) the red
intensity of the EF5 image at locations corresponding to each blood
vessel (these intensity measures encompass an approximately 25-
mm-diameter sampling area). A 50-mm rectangular sampling grid
was also superimposed over the EF5 image, and red intensities
were recorded at each of the sampling coordinates.
Closest-individual method
Instead of relying solely on vascular density measurements, the
￿closet-individual method￿ of Kayar (Kayar et al, 1982; Fenton and
Way, 1993) was also used to quantify diffusion distances. This
analysis is much better suited to image analysis techniques, as it
does not depend on distinguishing whether closely adjacent
vascular elements arise from two separate vessels or from two
discontinuous segments of the same vessel. A rectangular matrix of
sampling points (50 mm spacing) is first computer superimposed
over the selected tumour montage. Next, the distance from each
sampling point to the nearest blood vessel is determined. Finally,
the cumulative frequency distribution of these distances provides
an estimate of the probability of encountering vessels within any
specified distance from the tumour cells.
Figure 10 presents the cumulative frequency distributions for
each of the three vascular stains. For each tumour, either H33342
(open triangles) or DiOC7(3) (filled triangles) stain was injected
before tumour freezing and PECAM-1/CD31 staining was
performed for each (open and filled circles respectively) after the
fluorescent imaging. Image acquisition took approximately 20 min
per montage, and image analysis required an additional 5 min.
Cumulative frequency curves for total blood vessels were not
different between the two groups of tumours. While the DiOC7(3)
distribution is somewhat shifted to the left in relation to the
H33342, this shift was also not significant. To evaluate the repro-
ducibility of the colour segmentation procedures for each stain,
four tumour montages of each stain were analysed four separate
times to gauge the influence of the manual colour selections (using
a different manually determined colour segmentation range each
time). Overall distributions were not substantially altered by the
specific colour segmentation scheme chosen and, in each case,
were within the standard errors of the curves of Figure 10 (data not
A B
Figure 9 Enlarged comparison of DiOC7(3) staining (on left) and H33342 staining (on right). The H33342 stain diffuses much further from the vessels than the
DiOC7(3) stain, thus staining a large number of the surrounding tumour cells and producing a less precise delineation of perfused blood vessels. The two
sections compare vessels of similar size, but are from different tumours. Bar = 50 mmMeasures of tumour vascular development and hypoxia 469
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shown). Variations in the overall curves, as a result of analysis by
different observers, were also within the standard errors of each
curve (data not shown).
Based on the PECAM-1 staining, 95% of the tumour cells were
within 70 mm of the nearest anatomical vessel (Figure 10). This
distance cut-off provides a very rough guideline for the distance
oxygen might be expected to diffuse from a well-oxygenated
vessel (Vaupel, 1993) and indicates that these tumours would be
fairly well oxygenated if all of the blood vessels contained suffi-
cient oxygen. Based on the DiOC7(3) staining, however, only 76%
of the tumour cells were within 70 mm of the nearest perfused
vessel. If H33342 staining, rather than DiOC7(3), was used to
identify perfused vessels, only 68% of the tumour cells were esti-
mated to be within 70 mm of the nearest perfused vessel. Although
not significantly different, DiOC7(3) is clearly a superior indicator
of the number of perfused vessels in these tumours. The resolution
is improved as a result of: (1) a higher fluorescent intensity for the
DiOC7(3); (2) less photo-bleaching; and (3) an increase in the
contrast between vessels and background (see Figure 9).
Figure 11 presents an example of a three-dimensional mesh plot
of the relationships among EF5/Cy3 fluorescent intensity, intra-
vascular HbO2 saturation and distance to the blood vessel. For this
analysis, a 50-mm rectangular grid was first computer-superim-
posed over each EF5 image montage (with corresponding HbO2
map). At each grid point, the EF5 intensity was recorded, as well as
the distance to the highest HbO2 vessel located within a 150-mm
radius of the grid point, and the HbO2 saturation of this vessel. This
analysis only includes the coordinates of those vessels that were
selected for HbO2 determination, i.e. greater than 8.0 mm diameter,
and data from six KHT tumours were combined for the plot of
Figure 11. EF5 intensity peaks correspond to areas of the tumour
that were sufficiently hypoxic to bind the EF5 during the 1 h before
tumour freezing. If blood vessels intermittently opened and closed
during this period, EF5 binding would be reduced, and HbO2 levels
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at the time of freezing could be either high or low, resulting, at
times, in areas with both low HbO2 levels and low EF5 uptake. In
general, however, the most hypoxic regions of the tumour (as
predicted by the highest EF5 binding) are seen at the lowest HbO2
levels and at the furthest distances from the blood vessels.
DISCUSSION
Previous investigators have presented a variety of methods for
quantitating distributions of anatomical and functional tumour
microvessels, perhaps the most sophisticated being the techniques
of Rijken et al (1995) and van Geel et al (1996), who also related
total and perfused vascular areas to corresponding hypoxic areas.
The current study not only uses a different hypoxic marker (which
we believe to be an analogue variable rather than a binary segmen-
tation), but also differs from previous methods in several important
respects. (1) By using higher magnification, combined with colour
segmentation procedures, rather than a grey level threshold, a more
detailed image of individual blood vessels was obtained. (2) Instead
of relative vascular area, the ￿closest individual vessel￿ analysis was
performed to estimate the probability of encountering blood vessels
within any specified distance from the tumour cells. (3) DiOC7(3)
staining was substituted for the previous H33342, resulting in a
reduction in manual operator input and an increase in resolution. (4)
Intravascular HbO2 saturations were measured in sections adjacent
to the thin sections used for the vascular and hypoxic marker
staining, thus providing a quantitative validation of the hypoxic
marker intensities in situ and allowing the correlation of vascular
configuration with oxygen availability.
To identify anatomical blood vessels, the choice of a suitable
endothelial cell marker was a critical first step. As discussed by
Fox et al (1995), previous studies have used antibodies directed
against Factor VIII-related antigen (or CD34), vimentin, lectin,
alkaline phosphatase and type IV collagen, all of which suffer
from low specificity and sensitivity. We used a monoclonal anti-
body to CD-31 (PECAM-1), in combination with the AEC chro-
magen, to obtain sensitive and reliable microvessel staining in
frozen tissue sections. Instead of selecting a grey level threshold to
delineate vascular elements, we used a highly detailed, true colour
image, stored colour ranges and interactive colour selection to
distinguish blood vessels from artifacts. This colour segmentation
was highly reproducible, both for repeated counts by one observer
and when comparing counts by different observers.
Although tumour vascularity has most often been quantified in
terms of either capillary density or intercapillary distance, neither
provides average diffusion distance. In addition, the maximal
distance over which oxygen or drugs must diffuse to reach all
regions of the tumour is even more critical than average distance in
terms of both radio- and chemotherapy (Fenton and Way, 1993).
Capillary density also provides no information as to the uniformity
of the capillary spacing, which could in itself produce marked
gradients in oxygen delivery capacity (Loats et al, 1978). The
current measurements of vessel—tumour cell distances permit the
determination of both the median and the maximal distances that
oxygen and nutrients must diffuse to reach all points throughout
the tumour, as well as the entire distribution of these distances.
To quantify perfused blood vessels, previous studies have
generally relied on H33342 staining. As shown in the current
results, DiOC7(3) staining offers several key advantages over the
H33342. First, H33342 diffuses much further from the blood
vessels in 1 min than does DiOC7(3) in 4 min. As shown in Figure
9, this results in substantial overlap among the H33342-stained
vessels. Subsequent image processing is therefore much more
difficult, and the overlap between PECAM-1 and H33342 stained
vessels must be determined to estimate vascular density. With the
DiOC7(3) (Figure 9), vascular elements are: (1) more clearly
defined, (2) much brighter in contrast and intensity and (3) charac-
terized by a more limited range of colours. This allows an auto-
matic colour segmentation to be used for multiple DiOC7(3)
images, rather than requiring a separate manual segmentation for
each image, as required for the H33342 images. Finally, because
the DiOC7(3) vessels are more clearly defined, vascular density
counts can be performed directly on the DiOC7(3) images, rather
than by measuring the overlap between DiOC7(3) and PECAM-1.
The current methods allow a comprehensive, microregional
mapping of heterogeneities in three inter-related physiological
parameters: (1) total and perfused vascular structure, (2) intravas-
cular oxygen availability and (3) hypoxic development. Although
this detailed information is limited to one time point per tumour,
results obtained from matched-volume tumours can be combined
to define the physiological changes that accompany tumour
growth, local irradiation or various manipulations of blood flow
and oxygen delivery. Finally, by evaluating the changing relation-
ships among EF5/Cy3 intensity, HbO2 saturation and distance
from the vessel, a quantitative estimate of changes in oxygen
consumption between tumours is also possible.
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